The double blind phase-II results indicate that the combination might be safe and effectivenes was signifficatly higher in the combination group.
Abstract
--Frank
Tysabri + Copaxone trial results
Tysabri + Copaxone trial results
Treatment: Gilenya since 01/2011, CCSVI both IJV ballooned 09/2010, Tysabri stopped after 24 Infusions and positive JCV antibody test, after LDN, ABX Wheldon Regime for 1 year.
-
- Similar Topics
- Replies
- Views
- Last post
-
- 0 Replies
- 10782 Views
-
Last post by NHE
-
- 1 Replies
- 1141 Views
-
Last post by Scott1
-
- 9 Replies
- 11989 Views
-
Last post by ElliotB
-
- 0 Replies
- 1901 Views
-
Last post by NHE
-
- 0 Replies
- 2033 Views
-
Last post by NHE
-
- 1 Replies
- 1670 Views
-
Last post by frodo
-
- 0 Replies
- 7721 Views
-
Last post by NHE
-
- 0 Replies
- 10630 Views
-
Last post by NHE
-
- 0 Replies
- 2171 Views
-
Last post by NHE